Hefei National Laboratory for Physical Sciences at the Microscale and School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, PR China.
Int J Pharm. 2010 Jun 15;392(1-2):118-26. doi: 10.1016/j.ijpharm.2010.03.043. Epub 2010 Mar 25.
A brush-shaped polymer PHEMA-g-(PEI-b-PEG) with poly(2-hydroxyethyl methacrylate) (PHEMA) backbone and linear poly(ethylenimine)-b-poly(ethylene glycol) (PEI-b-PEG) side chains was synthesized and evaluated as a vector for potential cancer gene therapy. The characterizations by (1)H NMR and laser light scattering demonstrated the brush structure of the polymer. PHEMA-g-(PEI-b-PEG) was much less cytotoxic when compared with branched poly(ethylenimine) with M(w) of 25 kDa. The capacity of plasmid DNA condensation by PHEMA-g-(PEI-b-PEG) was demonstrated by gel retardation assay, and they formed nanosized complexes with surface zeta potential around 20 mV at N/P ratios higher than 5:1. The complexes of PHEMA-g-(PEI-b-PEG) with plasmid DNA were more efficiently internalized by BT474 cells in comparison with the complexes of PEI25K, leading to higher gene transfection in cells. Further investigation using complexes of PHEMA-g-(PEI-b-PEG) with plasmid DNA encoding wild-type p53 gene showed its potential as a carrier for cancer gene therapy. The complexes of PHEMA-g-(PEI-b-PEG) successfully induced elevated wild-type p53 expression in BT474 cells and led to enhanced apoptosis of BT474 cells. Transfection of wild-type p53 using the complexes also significantly increased the sensitivity of BT474 cells to doxorubicin chemotherapy, suggesting the potential of this carrier in cancer gene therapy.
一种具有聚(2-羟乙基甲基丙烯酸酯)(PHEMA)主链和线性聚(聚乙烯亚胺)-b-聚(乙二醇)(PEI-b-PEG)侧链的刷状聚合物 PHEMA-g-(PEI-b-PEG)被合成并评估为用于潜在癌症基因治疗的载体。(1)H NMR 和激光光散射的表征证明了聚合物的刷状结构。与 M(w)为 25 kDa 的支化聚乙烯亚胺相比,PHEMA-g-(PEI-b-PEG)的细胞毒性要低得多。通过凝胶阻滞实验证明了 PHEMA-g-(PEI-b-PEG)对质粒 DNA 的凝聚能力,并且当 N/P 比高于 5:1 时,它们形成表面 ζ 电位约为 20 mV 的纳米级复合物。与 PEI25K 的复合物相比,PHEMA-g-(PEI-b-PEG)与质粒 DNA 的复合物更有效地被 BT474 细胞内化,从而导致细胞中的基因转染更高。使用编码野生型 p53 基因的 PHEMA-g-(PEI-b-PEG)与质粒 DNA 的复合物进行的进一步研究表明,它具有作为癌症基因治疗载体的潜力。PHEMA-g-(PEI-b-PEG)的复合物成功地诱导 BT474 细胞中野生型 p53 的表达升高,并导致 BT474 细胞的凋亡增加。使用复合物转染野生型 p53 也显著增加了 BT474 细胞对阿霉素化疗的敏感性,表明该载体在癌症基因治疗中的潜力。